B ERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy ...

Triple negative breast cancer (TNBC) is usually detected at later stages. Unfortunately, by this time the cancer has moved or metastasized to other tissues throughout the body. One of the most common ...

Bone metastasizing and/or bone growing malignancies are a high unmet medical need. In breast and prostate cancer, bone is the ...

Why are lobular breast cancers found at later stages? What are the biological hallmarks of this disease? Are there ways to ...

The new approvals bring the number of denosumab biosimilars in the US to eight, but price reductions are not yet substantial.

Bone imaging plays a pivotal role in the diagnosis, treatment planning and follow‐up of patients with cancer metastasis. Advances in hybrid imaging modalities, particularly single-photon emission ...

RK-33 also showed promise in preventing breast cancer bone metastasis from occurring in the first place. Mice with breast cancer that had not spread to bone received the drug, and researchers observed ...

A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies. With this mda-9 mice model, Fisher and his team observed how ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has dosed the first patient in a Phase ...

Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found ...

MONTREAL—Denosumab significantly prolongs bone metastasis-free survival (BMFS) and delays time to bone metastasis in men with castration-resistant prostate cancer (CRPC), according to data presented ...